Liraglutide attenuates gefitinib-induced cardiotoxicity and promotes cardioprotection through the regulation of MAPK/NF-κB signaling pathways

por AlAsmari, Abdullah F., Ali, Nemat, AlAsmari, Fawaz, AlAnazi, Wael A., AlShammari, Musaad A., Al-Harbi, Naif O., Alhoshani, Ali, As Sobeai, Homood M., AlSwayyed, Mohammed, AlAnazi, Mohammed M., AlGhamdi, Nader S.
Publicado 2020